GlaxoSmithKline | L'Utile Operativo



Operating Profit Cambiamento Data
AbbVie USD 3.73B 5.22B 2025-03
Alcon AG USD 395M 63M 2024-12
Almirall EUR 53.03M 68.53M 2024-06
Amgen USD 2.31B 182M 2024-12
argenx SE USD 103.04M 86.87M 2024-12
AstraZeneca USD 3.67B 1.64B 2025-03
Bayer EUR 3.53B 7.35B 2024-12
Biogen USD 441.4M 24.4M 2024-12
Bristol-Myers Squibb USD 3.41B 2.62B 2025-03
Eli Lilly USD 5.41B 259.6M 2025-03
Fresenius EUR 469M 23M 2024-12
Fresenius Medical Care EUR 258.9M 204.1M 2024-12
Galapagos EUR -158708000 95.99M 2025-03
Genmab DKK 2.19B 89M 2024-12
Gilead Sciences USD 2.24B 215M 2025-03
GlaxoSmithKline GBP 2.22B 1.52B 2025-03
Glaxosmithkline GBP 702M 513M 2024-12
GRIFOLS EUR 371.86M 54.83M 2024-12
Hikma Pharmaceutical USD 327M 208M 2024-06
Lonza CHF 534M 194M 2024-06
Merck EUR 1.2B 100M 2024-12
Merck USD 5.87B 1.57B 2025-03
Novartis USD 2.28B 1.34B 2024-12
Novo Nordisk 33.82B 7.89B 2024-09
Orion EUR 77.9M 14.8M 2025-03
Pfizer USD 3.67B 4.08B 2025-03
Philips EUR 199M 139M 2024-12
Recordati EUR 162.68M 13.82M 2024-09
Regeneron Pharmaceuticals USD 591.7M 398.5M 2025-03
Roche Holding CHF 4.39B 1.04B 2024-12
Sanofi EUR 2.28B 1.42B 2025-03
Smith & Nephew USD 329M 1000K 2024-12
UCB EUR 163M 39M 2024-06



GlaxoSmithKline L'Utile Operativo - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.